{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:42:32Z","timestamp":1789036952013,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,7]]},"DOI":"10.7759\/cureus.43070","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T13:54:17Z","timestamp":1691416457000},"source":"Crossref","is-referenced-by-count":4,"title":["Hypercalcaemia of Immobility in Critically Ill Patients: Case Series"],"prefix":"10.7759","author":[{"given":"Muhamad S","family":"Aljeaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew  H","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/mco.0b013e328321cda6","article-title":"Bisphosphonates and metabolic bone disease in the ICU","volume":"12","author":"Hollander JM","year":"2009","unstructured":"Hollander JM, Mechanick JI. Bisphosphonates and metabolic bone disease in the ICU. Curr Opin Clin Nutr Metab Care. 2009, 12:190-5. 10.1097\/mco.0b013e328321cda6","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00805-w","article-title":"Critical illness and bone metabolism: where are we now and what is next?","volume":"27","author":"Cai Y","year":"2022","unstructured":"Cai Y, Kang F, Wang X. Critical illness and bone metabolism: where are we now and what is next?. Eur J Med Res. 2022, 27:177. 10.1186\/s40001-022-00805-w","journal-title":"Eur J Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2734-1","article-title":"The association between critical illness and changes in bone turnover in adults: a systematic review","volume":"25","author":"Orford N","year":"2014","unstructured":"Orford N, Cattigan C, Brennan SL, Kotowicz M, Pasco J, Cooper DJ. The association between critical illness and changes in bone turnover in adults: a systematic review. Osteoporos Int. 2014, 25:2335-46. 10.1007\/s00198-014-2734-1","journal-title":"Osteoporos Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001874","article-title":"Bone failure in critical illness","volume":"44","author":"Lee P","year":"2016","unstructured":"Lee P, Nair P, Eisman JA, Center JR. Bone failure in critical illness. Crit Care Med. 2016, 44:2270-4. 10.1097\/CCM.0000000000001874","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-017-0254-5","article-title":"Denosumab for treatment of immobilization-related hypercalcemia in a patient with end-stage renal disease","volume":"6","author":"Uehara A","year":"2017","unstructured":"Uehara A, Yazawa M, Kawata A, Hachisuka R, Shibagaki Y. Denosumab for treatment of immobilization-related hypercalcemia in a patient with end-stage renal disease. CEN Case Rep. 2017, 6:111-4. 10.1007\/s13730-017-0254-5","journal-title":"CEN Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0606-8","article-title":"Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients","volume":"9","author":"Mousseaux C","year":"2019","unstructured":"Mousseaux C, Dupont A, Rafat C, et al.. Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients. Ann Intensive Care. 2019, 9:133. 10.1186\/s13613-019-0606-8","journal-title":"Ann Intensive Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000117172.51403.af","article-title":"Assessment and management of patients with abnormal calcium","volume":"32","author":"Ariyan CE","year":"2004","unstructured":"Ariyan CE, Sosa JA. Assessment and management of patients with abnormal calcium. Crit Care Med. 2004, 32:S146-54. 10.1097\/01.ccm.0000117172.51403.af","journal-title":"Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241386","article-title":"Extreme hypercalcaemia caused by immobilisation due to acute spinal cord injury","volume":"14","author":"Tettero JM","year":"2021","unstructured":"Tettero JM, van Eeghen E, Kooter AJ. Extreme hypercalcaemia caused by immobilisation due to acute spinal cord injury. BMJ Case Rep. 2021, 14:e241386. 10.1136\/bcr-2020-241386","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2009.05.001","article-title":"Hypercalcaemia and acute renal failure after major burns: an under-diagnosed condition","volume":"36","author":"Kohut B","year":"2010","unstructured":"Kohut B, Rossat J, Raffoul W, Lamy O, Berger MM. Hypercalcaemia and acute renal failure after major burns: an under-diagnosed condition. Burns. 2010, 36:360-6. 10.1016\/j.burns.2009.05.001","journal-title":"Burns"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.11138\/ccmbm\/2016.13.1.046","article-title":"Immobilization induced hypercalcemia","volume":"13","author":"Cano-Torres EA","year":"2016","unstructured":"Cano-Torres EA, Gonz\u00e1lez-Cant\u00fa A, Hinojosa-Garza G, Castilleja-Leal F. Immobilization induced hypercalcemia. Clin Cases Miner Bone Metab. 2016, 13:46-7. 10.11138\/ccmbm\/2016.13.1.046","journal-title":"Clin Cases Miner Bone Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000001907","article-title":"Immobilization-related hypercalcemia in a COVID-19 patient with prolonged intensive care unit stay","volume":"101","author":"Mesland JB","year":"2022","unstructured":"Mesland JB, Collienne C, Laterre PF, Hantson P. Immobilization-related hypercalcemia in a COVID-19 patient with prolonged intensive care unit stay. Am J Phys Med Rehabil. 2022, 101:61-3. 10.1097\/PHM.0000000000001907","journal-title":"Am J Phys Med Rehabil"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1381\/096089202320995736","article-title":"Immobilization hypercalcemia in critical illness following bariatric surgery","volume":"12","author":"Alborzi F","year":"2002","unstructured":"Alborzi F, Leibowitz AB. Immobilization hypercalcemia in critical illness following bariatric surgery. Obes Surg. 2002, 12:871-3. 10.1381\/096089202320995736","journal-title":"Obes Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0086","article-title":"Immobilization-induced hypercalcemia in a patient with renal failure","volume":"2021","author":"Gandhi A","year":"2021","unstructured":"Gandhi A, Mortensen M, Sunny S, Techathaveewat P, Targovnik J, Alsayed M. Immobilization-induced hypercalcemia in a patient with renal failure. Endocrinol Diabetes Metab Case Rep. 2021, 2021:21-0086. 10.1530\/EDM-21-0086","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine J","year":"2015","unstructured":"Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015, 10:1257-72. 10.2215\/CJN.09750913","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-9993(99)90050-3","article-title":"Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury","volume":"80","author":"Massagli TL","year":"1999","unstructured":"Massagli TL, Cardenas DD. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury. Arch Phys Med Rehabil. 1999, 80:998-1000. 10.1016\/s0003-9993(99)90050-3","journal-title":"Arch Phys Med Rehabil"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp040300","article-title":"Treatment of electrolyte disorders in adult patients in the intensive care unit","volume":"62","author":"Kraft MD","year":"2005","unstructured":"Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005, 62:1663-82. 10.2146\/ajhp040300","journal-title":"Am J Health Syst Pharm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials","volume":"19","author":"Major P","year":"2001","unstructured":"Major P, Lortholary A, Hon J, et al.. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001, 19:558-67. 10.1200\/JCO.2001.19.2.558","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/173308-hypercalcaemia-of-immobility-in-critically-ill-patients-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:04Z","timestamp":1707508864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/173308-hypercalcaemia-of-immobility-in-critically-ill-patients-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.43070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,7]]}}}